Establishment Labs Missed Its Margin Forecast At 70.8% As Distributors Hit 60% Of Overseas Sales
The CFO blamed a heavier distributor mix against a planned 50%, and the CEO said the Middle East conflict is hurting orders.
Establishment Labs, which makes Motiva silicone gel-filled breast implants, delivered an adjusted gross margin of 70.8% in the third quarter, short of the 71.2% to 72.2% it had guided, Chief Financial Officer Sandra Harris said on the company's earnings call Thursday. Distributors made up about 60% of overseas revenue, against a planned 50%.
Distributor mix dents the margin
Responding to a Stifel analyst, Harris said the stronger distributor business adds revenue and gross profit dollars but moderates the margin percentage. Distributors sell at a lower margin than the company's direct business.
The adjusted margin was still 70 basis points above a year earlier, she said, as the higher-margin U.S. business grew from 22% of revenue to 35%. GAAP gross margin was 69.1%, against 70.1% a year ago; the adjusted figure excludes $1.3 million of restructuring-related inventory charges.
Full-year adjusted gross margin guidance now matches the roughly 70.7% average of the first nine months. Harris said even a more favorable direct-versus-distributor mix in the fourth quarter would have a limited effect on the full-year average.
Middle East orders slow
Asked by a Needham analyst about international markets, Chief Executive Officer Peter Caldini called them "pretty stable," with exceptions, the Middle East chief among them. The "ongoing conflict" has hurt both the market and the company's performance there, he said.
Orders still come from the region, he said, "but it's clearly not at the same level we've had historically." Revenue outside the U.S. rose 9.7% to $46 million, and direct markets grew 16%.
A TD Cowen analyst asked whether distributor orders were pulled forward. Harris said distributor growth was 14.4% in the first quarter, 4.4% in the second and 10% now, and the company remains confident in mid-single-digit growth for the year.
Raised revenue outlook, 2027 margin target
Total third-quarter revenue was $72 million, up 33.9%, and the company raised 2026 revenue guidance to more than $274 million from $269 million to $271 million. It also expects 25% revenue growth in 2027.
Harris said a gross margin gain of 50 to 100 basis points, or 0.5 to 1 percentage point, remains reasonable for 2027, depending on geographic and channel mix. Quarterly free cash flow turned positive for the first time, at $5.1 million.
Harris said the margin drivers are intact, and the company is holding to 50 to 100 basis points of expansion for 2027.
Sources
- Establishment Labs Hldgs Q3 2026 Earnings Call Transcript — benzinga.com
- Establishment Labs Q3 2026 Earnings Preview | Seeking Alpha — seekingalpha.com
- Establishment Labs® Reports Third Quarter 2026 Financial Results — businesswire.com